100% Quality Guarantee
PhD-Level Technical Support
Key Features

GenieFluor Violet 450 Anti-Mouse CD8a Antibody [53-6.7] (AGEL2974)

SKU AGEL2974
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Mouse
Host Species Rat
Isotype Rat IgG2a, κ
Clone 53-6.7
Conjugation AFViolet 450
€90 - €238

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

GenieFluor Violet 450 Anti-Mouse CD8a Antibody [53-6.7]

The GenieFluor Violet 450 Anti-Mouse CD8a Antibody (53-6.7) is a potent tool for researchers studying immune responses and T cell biology in mice. This monoclonal antibody, derived from hybridoma cells, specifically targets CD8a, a cell surface marker found on cytotoxic T cells involved in immune surveillance and response.With high reactivity and specificity for mouse samples, this antibody is a critical component for flow cytometry and immunofluorescence experiments, allowing for precise identification and analysis of CD8a-positive T cells. Its compatibility with various cell types and tissues makes it an invaluable resource for investigating immune cell populations and their roles in immunity, infection, and autoimmunity.

CD8a is a key player in adaptive immune responses, acting as a co-receptor for T cell receptor recognition and activation. Its expression on cytotoxic T cells allows for targeted killing of infected or abnormal cells, making it crucial for immune defense against pathogens and cancer. By targeting CD8a with this antibody, researchers can deepen their understanding of T cell-mediated immune responses and potentially uncover new therapeutic targets for immunomodulation and immunotherapy research.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose